A multidisciplinary surgical approach decreased death rates by 70% in patients with ovarian cancer. New research concluded that a multidisciplinary surgical approach can reduce a three-year death rate ...

An expert discusses how multidisciplinary collaboration can be enhanced through shared knowledge of available drugs and biomarkers among oncologists and pathologists, standardized interpretation ...

In part 2 of our interview, Diane Mahoney, PhD, DNP, FNP-BC, WHNP-BC, APRN, advocates for a multidisciplinary, community-centered approach to reduce ovarian cancer care disparities and stresses the ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators. Subscribe ...

Ovarian cancer is often detected at a late stage, providing poor prognoses, while benign ovarian growths can lead to unnecessary surgeries. A new combined fragmentomic–protein biomarkers test could ...

NICE has proposed age-based CA125 thresholds to improve early ovarian cancer detection while reducing unnecessary scans in ...

University of Manchester researchers have shown that analysis of fluid flushed through a fallopian tube holds promise for ...

A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, ...

Wistar Institute scientist Maureen Murphy wants to solve a decades-long mystery: Why is ovarian cancer often resistant to hormone therapy? In a recently published study, she shared a new theory as to ...